Severity
Moderate
ModerateActive
CPSC recall · Reported July 14, 2014
GSK Recalls Panadol Advance Bottles Due to Failure to Meet Child-Resistant Closure Requirement; Sold Exclusively in Puerto Rico
The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging …
GlaxoSmithKline (Gsk), of Moon Township, Penn. recalled This recall involves bottles of 100ct Panadol Advance pain relievers. The medicine was so… - a moderate-severity action.
GSK Recalls Panadol Advance Bottles Due to Failure to Meet Child-Resistant Closure Requir… was recalled by GlaxoSmithKline (Gsk), of Moon Township, Penn. in July 14, 2014. Reason: The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products conta…. Remedy: Consumers should immediately place the product out of a child's sight and reach, and cont…. Verify recall #14229 with the CPSC before acting.
The recall
GlaxoSmithKline (Gsk), of Moon Township, Penn. issued this moderate-severity CPSC recall-The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products conta….
- Moderate
- severity level
- July 14, 2014
- reported
Sourced from official CPSC enforcement records. Verify recall #14229 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This CPSC action (record #14229) was formally reported on July 14, 2014. It is classified under Moderate severity, with a current status of Active. GlaxoSmithKline (Gsk), of Moon Township, Penn. is listed as the recalling firm. Federal records list the affected scope as About 10,600.
The documented reason for this recall is: The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging Act to be sealed with child-resistant pa… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately place the product out of a child's sight and reach, and contact GSK for a refund. - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
About 10,600
Related Recalls
6
0 from same agency
Product description
This recall involves bottles of 100ct Panadol Advance pain relievers. The medicine was sold in white containers with a blue label, inside a blue box. "Panadol" and "Advance" are printed on the label. Lot numbers and dates codes are located on the left side panel of the box and on the left side of the label on the bottle, near the bar code. Lot numbers and date codes included in the recall are: Lot number: 14241, expiration date: 02/2015 Lot number: 14002, expiration date: 10/2014 Lot number: 13881, expiration date: 09/2014 Lot number: 13801, expiration date: 09/2014
Reason for recall
The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
Remedy, what to do
Consumers should immediately place the product out of a child's sight and reach, and contact GSK for a refund.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 14229 |
| Date reported | July 14, 2014 |
| Date initiated | July 14, 2014 |
| Recalling firm | GlaxoSmithKline (Gsk), of Moon Township, Penn. |
| Affected scope | About 10,600 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately place the product out of a child's sight and reach, and contact GSK for a refund.
- Check the recall number (14229) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
This recall involves bottles of 100ct Panadol Advance pain relievers. The medicine was sold in white containers with a blue label, inside a blue box. "Panadol" and "Advance" are printed on the label. Lot numbers and dates codes are located on the left side panel of the box and on the left side of the label on the bottle, near the bar code. Lot numbers and date codes included in the recall are: Lot number: 14241, expiration date: 02/2015 Lot number: 14002, expiration date: 10/2014 Lot number: 13881, expiration date: 09/2014 Lot number: 13801, expiration date: 09/2014. Recalled by GlaxoSmithKline (Gsk), of Moon Township, Penn.. Units affected: About 10,600.
Why was this product recalled? ▼
The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
What should consumers do? ▼
Consumers should immediately place the product out of a child's sight and reach, and contact GSK for a refund.
Which agency issued this recall? ▼
This recall was issued by the CPSC on July 14, 2014. Severity: Moderate. Recall number: 14229.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (14229) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
FDA Drug Low
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie c…
AbbVie Inc. · 2026-06-03
FDA Food Moderate
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bot…
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
FDA Drug Moderate
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by:…
Safecor Health, LLC · 2026-05-27
FDA Drug Moderate
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3…
IntegraDose Compounding Services LLC · 2026-05-27
FDA Drug Moderate
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, …
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported July 14, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.